AbbVie (ABBV)Sen. Alan Armstrong disclosed a purchase $15K–$50K

$15,001–$50,000

Reported range · official band, not an exact amount

116 days

Disclosure lag

Traded

Mar 27, 2026

Disclosed

Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 20, 2026Federal contract · $4K obligatedDepartment of Defense awarded AbbVie: $4K obligated to date
2. Feb 3, 2026Federal contract · $5K obligatedDepartment of Defense awarded AbbVie: $4.6K obligated to date
3. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
4. Feb 19, 2026FDAFDA drug approval: Venclexta
5. Feb 25, 2026Insider · Their largest sale since 2023Officer sold ~$5.15M of ABBV shares in the open market
6. Mar 2, 2026Insider · 1 personInsiders: 3 sales (~$4.4M)
7. Mar 4, 2026InsiderOfficer sold ~$1.22M of ABBV shares in the open market
8. Mar 5, 2026Federal contract · $3K obligatedDepartment of Defense awarded AbbVie: $3.4K obligated to date
9. Mar 6, 2026FDAFDA drug approval: Skyrizi
10. Mar 9, 2026Government · Federal Register noticeAspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications
11. Mar 9, 2026Government · Federal Register noticeGranting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
12. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
13. Mar 27, 2026 · this disclosureCongressDisclosed purchase of ABBV — reported range $15,001 - $50,000

What came next

1. Apr 3, 2026Company filing · Form 8-K · ResultsReported its results
2. Apr 23, 2026Government · Federal Register noticeKimberly Schaff Kiehl: Final Debarment Order
3. Apr 29, 2026Company filing · Form 8-K · ResultsReported its results
4. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
5. May 5, 2026CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
6. May 18, 2026FDARecall: PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product…
7. May 19, 2026Layoff notice · 2525 Dupont Drive Irvine CA 92612Layoff notice filed in CA: 85 employees
8. May 20, 2026FDAFDA drug approval: Venclexta
9. May 21, 2026FDAFDA drug approval: Linzess
10. May 27, 2026FDAFDA drug approval: Decnupaz
11. Jun 3, 2026Government · Federal Register noticeElite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications
12. Jun 8, 2026Government · Federal Register noticeDetermination That Protamine Sulfate (Protamine Sulfate) Intravenous; Solution, 50 Milligrams/5 Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
13. Jun 12, 2026FDAFDA drug approval: Skyrizi
14. Jun 26, 2026FDAFDA drug approval: Skyrizi
15. Jun 26, 2026Government · Federal Register noticeDetermination That RECTIV (Nitroglycerin) Ointment, 0.4%, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
16. Jun 29, 2026Government · Federal Register noticeDetermination of Regulatory Review Period for Purposes of Patent Extension; VYALEV
17. Jul 1, 2026Federal contract · $3K obligatedDepartment of Defense awarded AbbVie: $3.3K obligated to date
18. Jul 6, 2026Company filing · Form 8-K · ResultsReported its results
19. Jul 6, 2026Government · Federal Register noticeEndo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
20. Jul 7, 2026Government · Federal Register noticeCertain Antibody Drug Conjugates and Components Thereof and Products Containing the Same; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation; Termination of Investigation

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for AbbVie

For AbbVie, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 130 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABBV page.

Other recent filings by Sen. Alan Armstrong

• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at KKR & Co. (KKR)Jul 21, 2026
• Senate eFD periodic transaction report at Globe Life (GL)Jul 21, 2026
• Senate eFD periodic transaction report at Copart (CPRT)Jul 21, 2026

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at AbbVie

• House Clerk periodic transaction reportSep 18, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 25, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 13F-HRAug 17, 2026
• SEC Form 144Aug 14, 2026

Everything OQRO holds on this company is on its ABBV page.